BridgeMD
New treatment option for Ictus
Official title Percutaneous Ultrasound-guided Neuromodulation to Improve Gait Rehabilitation in Patients Who Have Suffered a Stroke.
ClinicalTrials.gov ID: NCT07196878
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if percutaneous ultrasound-guided neuromodulation (NMP-e) can improve gait rehabilitation in adults who have suffered a stroke. The main questions it aims to answer are: Does NMP-e improve walking speed in stroke survivors?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Be between 18 and 70 years of age;
- Have suffered a stroke (CVA);
- Be in the subacute or chronic phase of the disease;
- Be able to walk 10 meters without assistance from another person;
- Currently be undergoing physiotherapy with conservative techniques;
You likely can't join if
- Belonephobia (fear of needles);
- Allergy to needles or metals;
- Presence of uncontrolled coagulopathies;
- Presence of uncontrolled arterial disease;
- Pregnancy;
- Dermatological disorders;
See the full eligibility criteria
- Be between 18 and 70 years of age;
- Have suffered a stroke (CVA);
- Be in the subacute or chronic phase of the disease;
- Be able to walk 10 meters without assistance from another person;
- Currently be undergoing physiotherapy with conservative techniques;
- Be able to understand the technique being applied;
- Sign the informed consent form.
- Belonephobia (fear of needles);
- Allergy to needles or metals;
- Presence of uncontrolled coagulopathies;
- Presence of uncontrolled arterial disease;
- Pregnancy;
- Dermatological disorders;
- Presence of diseases such as systemic inflammatory disorders (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or septic arthritis);
- Presence of diseases such as tumors, cancer, or metastases;
- Having received invasive physiotherapy treatment in the last 4 weeks.
The study team makes the final eligibility decision.
Where it's taking place
- Zaragoza, Aragon, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zaragoza, Aragon, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.